Limited lobular carcinoma cases and incomplete tumor marker data constrained stratified analyses by histology, whereas receptor status (ER, PR, HER2) and tumor grade were not significant predictors of [18F]NaF PET positivity, likely reflecting small subgroups and absent molecular subtype stratification. The gene discussed is ERBB2; the disease is breast lobular carcinoma.